MapLight Therapeutics (MPLT) Gains from Investment Securities (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Gains from Investment Securities came in at $265000.0 in Q4 2025, up 117.16% year-on-year from $122028.0 in Q4 2024, and down 71.6% quarter-over-quarter from $933010.0 in Q3 2025.
MapLight Therapeutics (MPLT) Gains from Investment Securities (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Gains from Investment Securities across 2 years of filings, most recently posting $265000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $265000.0, up 117.16% year-over-year; the trailing twelve-month figure through Sep 2025 was $933010.0 (changed N/A YoY), and the FY2025 annual result was $3687.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $265000.0 for Q4 2025 at MapLight Therapeutics, down from $933010.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $933010.0 in Q3 2025 to a low of -$1.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 265,000.00 |
| Dec 31, 2025 | 265,000.00 |
| Sep 30, 2025 | 933,010.00 |
| Sep 30, 2025 | 933,010.00 |
| Dec 31, 2024 | -1.54 Mn |
| Dec 31, 2024 | -1.54 Mn |